| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | THC | Common Stock | Options Exercise | $1.17 M | +56.6 K | $20.60 | 56.6 K | Nov 12, 2021 | Direct | F1 | |
| transaction | THC | Common Stock | Sale | -$4.44 M | -56.6 K | -100% | $78.46 | 0 | Nov 12, 2021 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | THC | 2018 February Performance Stock Options (Right to Buy) | Options Exercise | -$1.17 M | -56.6 K | -100% | $20.60 | 0 | Nov 12, 2021 | Common Stock | 56.6 K | $20.60 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | This stock option was exercised and the resulting shares were sold in open market broker transactions. |
| F2 | The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $78.09 to $78.80. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price |